Search Results - "Thio, H.B"

Cost‐effectiveness of omalizumab for the treatment of chronic spontaneous urticaria by Kanters, T.A., Thio, H.B., Hakkaart, L.

“…Summary Background Chronic spontaneous urticaria (CSU) is a skin disease with itchy hives and/or angio‐oedema that last for at least 6 weeks without an obvious…”
Get full text

Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients by Wakkee, M, Thio, H.B, Prens, E.P, Sijbrands, E.J.G, Neumann, H.A.M

“…Abstract Psoriasis is a chronic inflammatory skin disease that is associated with an increased cardiovascular risk profile. The systemic inflammation present…”
Get full text

Effects of monomethylfumarate on dendritic cell differentiation by Litjens, N.H.R., Rademaker, M., Ravensbergen, B., Thio, H.B., van Dissel, J.T., Nibbering, P.H.

“…Summary Background  Fumaric acid esters (FAE) are effective against psoriasis vulgaris and monomethylfumarate (MMF) is believed to be the most bioactive…”
Get full text

Neoplasms of the Facial Skin by Hajdarbegovic, E., MD, van der Leest, R.J.T., MD, Munte, K., MD, Thio, H.B., MD, PhD, Neumann, H.A.M., MD, PhD

“…Neoplasms of the skin are found most often on the face. Malignant tumors of the facial skin pose a challenge in treatment, prohibiting compromises between…”
Get full text

奥马珠单抗治疗自发慢性荨麻疹的成本效益 by Kanters, T.A., Thio, H.B., Hakkaart, L.

Get full text

European S3-Guidelines on the systemic treatment of psoriasis vulgaris - Update 2015 - Short version - EDF in cooperation with EADV and IPC by Nast, A., Gisondi, P., Ormerod, A.D., Saiag, P., Smith, C., Spuls, P.I., Arenberger, P., Bachelez, H., Barker, J., Dauden, E., de Jong, E.M., Feist, E., Jacobs, A., Jobling, R., Kemény, L., Maccarone, M., Mrowietz, U., Papp, K.A., Paul, C., Reich, K., Rosumeck, S., Talme, T., Thio, H.B., van de Kerkhof, P., Werner, R.N., Yawalkar, N.

Get full text

Cost‐effectiveness of omalizumab in chronic spontaneous urticaria by Kanters, T.A., Thio, H.B., Hakkaart, L.

“…Summary Chronic spontaneous urticaria (CSU) is a skin disease which causes itchy hives that last for at least 6 weeks, and without an obvious external trigger…”
Get full text

European S3‐Guideline on the systemic treatment of psoriasis vulgaris – Update Apremilast and Secukinumab – EDF in cooperation with EADV and IPC by Nast, A., Spuls, P.I., Kraaij, G., Gisondi, P., Paul, C., Ormerod, A.D., Saiag, P., Smith, C.H., Dauden, E., Jong, E.M., Feist, E., Jobling, R., Maccarone, M., Mrowietz, U., Papp, K.A., Reich, K., Rosumeck, S., Talme, T., Thio, H.B., Kerkhof, P., Werner, R.N., Dressler, C.

Get full text

An approach for the transition from systemic immunosuppressants to dupilumab by Wijs, L.E.M., Thyssen, J.P., Vestergaard, C., Thio, H.B., Kunkeler, A.C.M., Biedermann, T., Hijnen, D.J.

Get full text

Efficacy, effectiveness and safety of fumaric acid esters in the treatment of psoriasis: a systematic review of randomized and observational studies by Balak, D.M.W., Fallah Arani, S., Hajdarbegovic, E., Hagemans, C.A.F., Bramer, W.M., Thio, H.B., Neumann, H.A.M.

“…Summary Fumaric acid esters (FAEs) are increasingly used as a systemic treatment for psoriasis, but there are still uncertainties regarding their suitability…”
Get full text

Highlights of the updated Dutch evidence‐ and consensus‐based guideline on psoriasis 2017 by Kraaij, G.E., Balak, D.M.W., Busard, C.I., Cranenburgh, O.D., Chung, Y., Driessen, R.J.B., Groot, M., Jong, E.M.G.J., Kemperman, P.M.J.H., Kort, W.J.A., Karsch, S.A., Lamberts, A., Lecluse, L.L.A., Lümig, P.P.M., Menting, S.P., Prens, E.P., Reek, J.M.P.A., Seyger, M.M.B., Thio, H.B., Veldkamp, W.R., Wakkee, M., Nast, A., Jacobs, A., Rosumeck, S., Spuls (Chair), P.I.

“…Linked Comment: Ormerod. Br J Dermatol 2019; 180:11…”
Get full text

A prospective randomized controlled trial comparing infliximab and etanercept in patients with moderate‐to‐severe chronic plaque‐type psoriasis: the Psoriasis Infliximab vs. Etanercept Comparison Evaluation (PIECE) study by Vries, A.C.Q., Thio, H.B., Kort, W.J.A., Opmeer, B.C., Stok, H.M., Jong, E.M.G.J., Horvath, B., Busschbach, J.J.V., Nijsten, T.E.C., Spuls, Ph.I.

“…Summary Background There are currently no independent data available comparing infliximab and etanercept for the treatment of psoriasis. Objectives To compare…”
Get full text

Seborrhoeic keratosis removal in a multicentre phase I/II clinical trial using a novel topical formulation (BL-5010) by Levy-Nissenbaum, E., Thio, H.B., Burstein, P., Thaci, D.

Get full text

Fumarates vs. methotrexate in moderate to severe chronic plaque psoriasis: a multicentre prospective randomized controlled clinical trial by Fallah Arani, S., Neumann, H., Hop, W.C.J., Thio, H.B.

“…Summary Background  Methotrexate and fumarates are effective systemic therapies for moderate to severe psoriasis according to the European S3 guidelines…”
Get full text

Progressive multifocal leukoencephalopathy associated with fumaric acid esters treatment in psoriasis patients by Balak, D.M.W., Hajdarbegovic, E., Bramer, W.M., Neumann, H.A.M., Thio, H.B.

“…Background Fumaric acid esters (FAEs) are a systemic treatment for psoriasis considered to have a favourable long‐term safety profile without an increased risk…”
Get full text

E-health in caring for patients with atopic dermatitis: a randomized controlled cost-effectiveness study of internet-guided monitoring and online self-management training by van Os-Medendorp, H., Koffijberg, H., Eland-de Kok, P.C.M., van der Zalm, A., de Bruin-Weller, M.S., Pasmans, S.G.M.A., Ros, W.J.G., Thio, H.B., Knol, M.J., Bruijnzeel-Koomen, C.A.F.M.

“…Summary Background  The Dermatology Department of the University Medical Centre Utrecht, the Netherlands, developed an e‐health portal for patients with atopic…”
Get full text

Effectiveness and safety of fumaric acid esters in children with psoriasis: a retrospective analysis of 14 patients from the Netherlands: Fumaric acid esters for paediatric psoriasis by Balak, D.M.W., Oostveen, A.M., Bousema, M.T., Venema, A.W., Arnold, W.P., Seyger, M.M.B., Thio, H.B.

Get full text

Regulated genes in psoriatic skin during treatment with fumaric acid esters by Onderdijk, A.J., Balak, D.M.W., Baerveldt, E.M., Florencia, E.F., Kant, M., Laman, J.D., van IJcken, W.F.J., Racz, E., de Ridder, D., Thio, H.B., Prens, E.P.

“…Summary Background Fumaric acid esters (FAEs) are widely used in Europe for the treatment of psoriasis because of their clinical efficacy and favourable safety…”
Get full text

Fumarates vs. methotrexate in moderate to severe chronic plaque psoriasis: a multicentre prospective randomized controlled clinical trial: Fumarates vs. methotrexate for chronic plaque psoriasis by Fallah Arani, S., Neumann, H., Hop, W.C.J., Thio, H.B.

Get full text

奥马珠单抗治疗自发慢性荨麻疹的成本效益 by Kanters, T.A., Thio, H.B., Hakkaart, L.

“…Summary…”
Get full text